Morning Market Losers By: Benzinga via Benzinga October 17, 2014 at 10:03 AM EDT Repros Therapeutics (NASDAQ: RPRX) shares dropped 39.53% to $6.36 following announcement the FDA meeting will be Type C guidance meeting ... Read More >> Related Stocks: Athena Technology Acquisition Corp Cl A Capital One Financial M&T Bank Myriad Genetics Inc SanDisk Corp Urban Outfitters